Plenary Speakers
Jiri Adamec, PhD
Stanley S. Scott Cancer Center, Department of Interdisciplinary Oncology, New Orleans (USA)
Health Disparities and Affordable Precision Medicine
Renã A.S. Robinson, PhD
Department of Chemistry, Vanderbilt University, Nashville (USA)
Proteomics advances in aging and Alzheimer’s disease
Steven A. Carr, PhD
Senior Director of Proteomics and Institute Scientist, Broad Institute of MIT and Harvard, Cambridge (USA)
Quantitative proteomics in Biology and Clinical Medicine
Mamuka Kvaratskhelia, PhD
University of Colorado School of Medicine. Colorado (USA)
Ellen D. McPhail, PhD
Department of Laboratory Medicine and Pathology Tissue Proteomics Clinical Laboratory Mayo Clinic, Rochester (USA)
Proteomics-based classification of membranous nephropathy
Nataly Kravchenko-Balasha, PhD
The Institute of Biomedical and Oral Research, The Hebrew University of Jerusalem, Jerusalem (Israel)
Daniel Martins-de-Souza, PhD
University of Campinas – Unicamp, Campinas (Brazil)
Employing neuroproteomics to decipher the molecular underpinnings of Schizophrenia
Jean Pieters, PhD
Biozentrum, University of Basel, Basel (Switzerland)
Cell population size control by coronin proteins
Julio Chirinos, PhD
Hospital of the University of Pennsylvania, Philadelphia (USA)
Deciphering Human Heart Failure with Proteomics Approaches: A focus on risk stratification and underlying biology
Pierre-Olivier Schmit, PhD
Bruker
4D proteomics : addressing the challenges of clinical proteomics research